StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
407
This month
12
This week
2
This year
12
Publishing Date
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
4
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 01
3
2022 - 02 - 23
2
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Sector
Commercial services
7
Communications
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
6
Energy minerals
1
Finance
4
Finance and insurance
1
Health services
9
Health technology
407
Industrial services
2
Manufacturing
138
Mining, quarrying, and oil and gas extraction
1
N/a
13
Non-energy minerals
1
Process industries
6
Producer manufacturing
8
Professional, scientific, and technical services
4
Retail trade
1
Tags
Alliances
20
America
15
Antibody
15
Application
5
Approval
5
Biotech
19
Breast cancer
13
Cancer
93
Cel
5
China
7
Clinical-trials-phase-iii
9
Collaboration
12
Covid
7
Covid-19
8
Diabetes
12
Diagnostic
10
Diagnostics
9
Disease
26
Drug
58
Drug delivery
12
Earnings
5
Enhertu
14
Europe
8
Events
7
Expected
8
Fda
5
Financial results
9
For
33
Global
38
Growing
13
Growth
63
Immunotherapy
6
Initiated
5
Iot
8
License
10
Liver
15
Lung
7
Lung cancer
10
Market
115
N/a
310
Partnership
5
People
8
Pharma
6
Phase 3
7
Positive
9
Potential
5
Regulatory
6
Report
47
Research
42
Respiratory
7
Results
20
Review
6
Risk
5
System
7
Test
6
Therapeutics
37
Therapy
20
Treatment
29
Trial
25
Vaccine
19
Entities
3m company
8
Abbott laboratories
46
Abbvie inc.
47
Adaptimmune therapeutics plc
4
Agilent technologies, inc.
3
Alexion pharmaceuticals, inc.
8
Alkermes plc
4
Amgen inc.
56
Aptargroup, inc.
4
Artelo biosciences, inc.
9
Astellas pharma inc
19
Astrazeneca plc
407
Avenue therapeutics, inc.
5
Aveo pharmaceuticals, inc.
5
Bausch health companies inc.
7
Baxter international inc.
10
Becton, dickinson and company
4
Biogen inc.
11
Biontech se
4
Boston scientific corporation
5
Bristol-myers squibb company
36
Compugen ltd.
3
Csl ltd
5
Eli lilly and company
61
Endo international plc
6
Exelixis, inc.
3
F-star therapeutics inc.
3
Fibrogen, inc
4
Fortress biotech, inc.
20
Galapagos nv
6
Genprex, inc.
4
Gilead sciences, inc.
8
Glaxosmithkline plc
125
Hutchison china meditech limited
10
Illumina, inc.
3
Innate pharma s.a.
3
Innate pharma sa
4
Insulet corporation
4
Johnson & johnson
80
Journey medical corp
3
Koninklijke philips n.v.
7
Mallinckrodt plc
3
Medtronic plc
9
Mitsubishi chemical holdings corp
4
Moderna, inc.
5
Mustang bio, inc.
3
Mylan n.v.
10
Neurocrine biosciences, inc.
4
Novartis ag
118
Novavax, inc.
4
Novo nordisk a/s
18
Opko health, inc.
3
Pfizer, inc.
32
Puma biotechnology inc
3
Sanofi
136
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
38
Thermo fisher scientific inc
8
Viatris inc.
15
Symbols
AAPL
687
ABB
870
ABBV
636
ABLZF
611
ABT
1020
AMGN
476
ARVL
2407
AZN
407
BDX
555
BMY
444
BNPQF
971
BNPQY
971
BNPZY
970
BSX
398
CNY
969
CSCO
598
DHR
483
ERIC
1022
EXTR
478
FNCTF
3460
FRBA
397
GE
646
GLAXF
398
GOOG
513
GOOGL
513
GSK
597
HON
1073
HUBS
1010
IBM
418
INR
972
INTC
617
JNJ
2875
LLY
1127
LTUM
528
LYV
459
MDT
868
MLPY
970
MMM
634
MS
2595
MS-PE
398
MSFT
835
NOK
477
NOKBF
460
NVO
398
NVS
728
NVSEF
525
ORCL
774
PFE
502
PHG
613
PPRUF
593
PPRUY
594
SAP
942
SAPGF
677
SNOW
517
SNY
2651
SNYNF
1706
TMO
929
TOT
995
URR
968
VZ
639
Exchanges
Amex
6
Lse
109
Nasdaq
407
Nyse
246
Tsx
1
Crawled Date
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 03 - 01
2
2022 - 02 - 23
2
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
3
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Crawled Time
00:00
4
00:20
2
01:00
5
01:12
1
02:00
7
03:00
10
03:10
1
04:00
8
04:09
1
04:20
2
05:00
3
06:00
10
07:00
11
08:00
9
09:00
14
09:07
1
10:00
9
11:00
25
12:00
25
12:15
2
12:20
5
12:30
4
13:00
17
13:02
1
13:15
5
13:20
7
13:30
6
13:37
1
14:00
21
14:15
3
14:20
3
14:30
1
15:00
20
15:15
3
15:20
7
15:30
2
16:00
27
17:00
25
18:00
20
18:12
1
19:00
21
19:11
1
20:00
18
20:20
1
21:00
18
21:03
1
22:00
9
22:10
1
23:00
6
23:05
1
23:09
1
Source
investor.aveooncology.com
2
ir.chemocentryx.com
1
www.biospace.com
97
www.chi-med.com
2
www.globenewswire.com
43
www.prnewswire.com
261
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Azn
save search
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published:
2023-01-25
(Crawled : 03:00)
- prnewswire.com
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
1.2%
|
O:
0.26%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
|
-2.06%
|
O:
-2.56%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-0.18%
|
O:
-0.2%
H:
0.0%
C:
0.0%
america
for
growth
market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published:
2023-01-23
(Crawled : 13:00)
- biospace.com/
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.19%
|
O:
-1.28%
H:
0.57%
C:
-1.6%
acquire
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
VTRS
|
$11.89
2.15%
2.1%
9.9M
|
Health Technology
|
-1.69%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
News
|
$573.63
-0.65%
-0.03%
1.1M
|
Health Technology
|
-2.8%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
$138.09
0.4%
1.38%
1.1M
|
Health Technology
|
-1.04%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-4.04%
|
O:
0.08%
H:
0.01%
C:
-1.16%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-3.3%
|
O:
-1.47%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
-0.67%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-4.23%
|
O:
-1.13%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.95
-1.01%
0.0%
4.9M
|
Health Technology
|
-2.46%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-2.65%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
A
|
$290.0
-0.66%
-0.66%
890K
|
Health Technology
|
1.46%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.71%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
News
|
$253.68
-0.47%
-0.47%
2.1M
|
Health Technology
|
-5.38%
|
O:
0.0%
H:
0.41%
C:
-1.87%
for
therapy
growth
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
Published:
2023-01-18
(Crawled : 15:00)
- globenewswire.com
HCM
|
$19.88
0.25%
0.25%
370K
|
Health Technology
|
19.03%
|
O:
1.32%
H:
4.49%
C:
1.01%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.71%
|
O:
1.36%
H:
0.33%
C:
-1.13%
orpathys
drug
for
agreement
china
Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES
Published:
2023-01-17
(Crawled : 17:00)
- globenewswire.com
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-7.07%
|
O:
0.86%
H:
0.03%
C:
-1.23%
group
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published:
2023-01-13
(Crawled : 13:00)
- prnewswire.com
TAK
|
News
|
$16.03
-0.43%
0.0%
3.7M
|
Health Technology
|
2.53%
|
O:
0.96%
H:
0.0%
C:
0.0%
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
|
-6.56%
|
O:
1.08%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-0.73%
|
O:
0.8%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-3.18%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.43%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
0.3%
|
O:
1.89%
H:
0.0%
C:
0.0%
BMRN
M
|
$117.27
0.25%
0.25%
1.2M
|
Health Technology
|
5.64%
|
O:
2.13%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
treatment
disease
expected
Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published:
2023-01-12
(Crawled : 22:00)
- prnewswire.com
TAK
|
News
|
$16.03
-0.43%
0.0%
3.7M
|
Health Technology
|
2.53%
|
O:
0.96%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.43%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
0.3%
|
O:
1.89%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
global
report
therapeutics
cancer
market
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published:
2023-01-10
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
$130.65
0
|
Health Technology
|
-9.25%
|
O:
-1.28%
H:
0.0%
C:
-0.82%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-7.84%
|
O:
-0.33%
H:
0.13%
C:
-1.28%
covid-19
research
global
report
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published:
2023-01-09
(Crawled : 10:00)
- prnewswire.com
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
2.81%
|
O:
1.76%
H:
0.0%
C:
0.0%
LLY
|
News
|
$342.1
-1.7%
0.12%
2.3M
|
Health Technology
|
-3.85%
|
O:
1.12%
H:
0.27%
C:
-3.89%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
1.59%
|
O:
1.82%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.57%
|
O:
1.67%
H:
0.86%
C:
-0.21%
research
market
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
Published:
2023-01-05
(Crawled : 16:00)
- biospace.com/
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.42%
|
O:
-2.09%
H:
0.0%
C:
0.0%
lung
for
biomarker
cancer
study
Genomic Vision announces successful beta testing of FiberSmart®
Published:
2023-01-05
(Crawled : 07:00)
- globenewswire.com
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.42%
|
O:
-2.09%
H:
0.0%
C:
0.0%
fibersmart
genomic
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published:
2023-01-04
(Crawled : 23:00)
- prnewswire.com
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.65%
|
O:
-0.84%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-5.77%
|
O:
0.22%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-1.5%
|
O:
-3.07%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-6.42%
|
O:
-2.09%
H:
0.0%
C:
0.0%
treatment
patent
global
report
growing
diabetes
growth
market
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.39%
|
O:
-0.03%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.3
-0.11%
0.14%
3.5M
|
Health Technology
|
0.54%
|
O:
-0.14%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-0.08%
|
O:
-0.39%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-3.1%
|
O:
-0.5%
H:
0.0%
C:
0.0%
global
report
sanofi
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
PFE
|
$43.79
-1.04%
0.0%
23M
|
Health Technology
|
-13.95%
|
O:
0.02%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.39%
|
O:
-0.03%
H:
0.0%
C:
0.0%
JNJ
|
News
3 d
|
$168.23
-0.39%
-0.04%
6M
|
Health Technology
|
-5.05%
|
O:
-0.01%
H:
0.0%
C:
0.0%
BMY
|
News
|
$72.45
-0.74%
0.0%
5.4M
|
Health Technology
|
1.11%
|
O:
0.13%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.49
-0.66%
-0.66%
1.1M
|
Health Technology
|
-0.08%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
F
|
$83.7
0.1%
0.1%
4.1M
|
Health Technology
|
-1.92%
|
O:
-0.12%
H:
0.0%
C:
0.0%
EXEL
M
|
$17.48
-1.3%
-1.32%
1.6M
|
Health Technology
|
13.09%
|
O:
0.03%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-3.1%
|
O:
-0.5%
H:
0.0%
C:
0.0%
global
disease
report
therapeutics
cancer
market
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Need of Potential Treatments to Improve Quality of Life Drives Sector
Published:
2022-12-22
(Crawled : 17:00)
- prnewswire.com
JAZZ
|
$155.65
0.66%
0.66%
360K
|
Health Technology
|
-2.42%
|
O:
0.91%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-2.81%
|
O:
-0.12%
H:
0.0%
C:
0.0%
lung
global
report
life
potential
cancer
market
Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
Published:
2022-12-19
(Crawled : 13:20)
- globenewswire.com
AZNCF
|
$130.65
0
|
Health Technology
|
-5.31%
|
O:
-1.12%
H:
0.06%
C:
0.06%
VERU
|
News
|
$5.91
0.0%
1.8M
|
Health Technology
|
14.88%
|
O:
-1.28%
H:
0.4%
C:
-3.99%
FBIO
|
News
|
$0.9122
2.49%
2.43%
450K
|
Health Technology
|
51.28%
|
O:
-2.44%
H:
0.0%
C:
0.0%
ATXI
|
News
|
$1.36
-12.26%
-13.97%
1M
|
Health Technology
|
11.74%
|
O:
-0.4%
H:
1.63%
C:
-6.5%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-3.08%
|
O:
-0.29%
H:
0.01%
C:
-0.62%
biotech
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
Published:
2022-12-16
(Crawled : 13:00)
- biospace.com/
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.78%
|
O:
-2.78%
H:
0.0%
C:
0.0%
cancer
The Worldwide mRNA Therapeutics Industry is Expected to Reach $37.7 billion by 2030
Published:
2022-12-15
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
$130.65
0
|
Health Technology
|
-6.52%
|
O:
0.14%
H:
0.4%
C:
-1.41%
SGMO
|
$3.58
3.77%
3.63%
880K
|
Health Technology
|
0.0%
|
O:
-1.16%
H:
1.17%
C:
-3.23%
MRNA
S
|
$189.34
-2.02%
-2.06%
3.3M
|
Health Technology
|
-0.93%
|
O:
6.44%
H:
2.33%
C:
-0.17%
CVAC
|
$11.4
1.33%
1.32%
770K
|
Health Technology
|
56.9%
|
O:
-1.39%
H:
1.41%
C:
-4.24%
CRSP
|
$52.74
4.5%
4.3%
880K
|
Health Technology
|
0.56%
|
O:
-2.23%
H:
2.67%
C:
-3.2%
BNTX
|
$143.69
0.81%
0.8%
440K
|
Health Technology
|
-23.39%
|
O:
0.13%
H:
1.45%
C:
-2.28%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.9%
|
O:
-0.13%
H:
0.0%
C:
0.0%
expected
mrna
therapeutics
Peripheral neuropathy treatment market size to increase by USD 372.56 million: North America to contribute 33% of market growth - Technavio
Published:
2022-12-15
(Crawled : 03:00)
- prnewswire.com
ENDPQ
|
News
|
$0.1007
0
|
n/a
|
22.06%
|
O:
-3.03%
H:
3.38%
C:
-7.75%
AZNCF
|
$130.65
0
|
Health Technology
|
-6.52%
|
O:
0.14%
H:
0.4%
C:
-1.41%
VTRS
|
$11.89
2.15%
2.1%
9.9M
|
Health Technology
|
2.96%
|
O:
-0.44%
H:
0.0%
C:
0.0%
NVS
|
News
4 d
|
$89.49
-0.39%
0.01%
1.7M
|
Health Technology
|
-2.83%
|
O:
-0.15%
H:
0.08%
C:
-1.07%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-5.9%
|
O:
-0.13%
H:
0.0%
C:
0.0%
america
treatment
growth
market
Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Published:
2022-12-14
(Crawled : 19:00)
- biospace.com/
AZNCF
|
$130.65
0
|
Health Technology
|
-5.7%
|
O:
-0.93%
H:
1.82%
C:
1.82%
GNPX
|
$1.35
3.05%
2.96%
93K
|
Health Technology
|
6.5%
|
O:
-3.25%
H:
0.0%
C:
0.0%
AZN
|
$65.54
-0.68%
-0.69%
3.1M
|
Health Technology
|
-4.75%
|
O:
1.23%
H:
0.0%
C:
0.0%
reqorsa
lung
trial
approval
review
cancer
← Previous
1
2
3
4
5
6
7
8
9
…
20
21
Next →
Gainers vs Losers
66%
34%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.